Incidence and timing of common adverse events in lenvatinib-treated patients with radioiodine-refractory thyroid cancer from the SELECT trial Meeting Abstract


Authors: Haddad, R.; Schlumberger, M.; Wirth, L. J.; Sherman, E. J.; Shah, M. H.; Robinson, B.; Dutcus, C. E.; Young, L.; Teng, A.; Gianoukakis, A.; Sherman, S. I.
Abstract Title: Incidence and timing of common adverse events in lenvatinib-treated patients with radioiodine-refractory thyroid cancer from the SELECT trial
Meeting Title: 2016 Annual Scientific Meeting of the Endocrine Society of Australia and the Society for Reproductive Biology and Australia and New Zealand Bone and Mineral Society
Journal Title: Clinical Endocrinology
Volume: 86
Issue: Suppl. 1
Meeting Dates: 2016 Aug 21-24
Meeting Location: Queensland, Australia
ISSN: 0300-0664
Publisher: Wiley Blackwell  
Date Published: 2017-01-01
Start Page: 68
Language: English
ACCESSION: WOS:000393453600174
PROVIDER: wos
PUBMED: 28111774
DOI: 10.1111/cen.13259
Notes: Meeting Abstract: 427 -- Source: Wos
Altmetric Score
MSK Authors
  1. Eric J Sherman
    149 Sherman